Collectively, the network pharmacological analysis indicated that QM may inhibit the TGF-β signaling pathway to mediate ECM accumulation, fibroblast activation, and EMT to prevent the progression of PF. The gene discussed is TGFB1; the disease is pemphigus foliaceus.